| Study of M5049 in Healthy Japanese and Caucasian Participants (NCT04880213) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2021-05-06 |
| Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With Relapsed Refractory Multiple Myeloma, The SCOPE Trial (NCT04764942) | Mayo Clinic | 2021-05-06 |
| A Study of JNJ-56136379 in Healthy Participants (NCT04853524) | Janssen Research & Development, LLC | 2021-05-06 |
| An Open-label, Phase I/II Study of Manganese Plus Radiotherapy in Patients With Metastatic Solid Tumors or Lymphoma (NCT04873440) | Chinese PLA General Hospital | 2021-05-06 |
| Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy (NCT04652570) | Tenet Medicines | 2021-05-05 |
| Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative Colitis (NCT04862741) | Landos Biopharma Inc. | 2021-05-05 |
| CD19 and BCMA Targeted Fast Dual CAR-T for CD19+ Refractory/Relapsed B-NHL (NCT04877080) | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2021-05-05 |
| A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies (NCT04830137) | Nurix Therapeutics, Inc. | 2021-05-05 |
| A Study of Evorpacept (ALX148) With Venetoclax and Azacitidine for Acute Myeloid Leukemia (ASPEN-05) (NCT04755244) | ALX Oncology Inc. | 2021-05-05 |
| First-In-Human Study of GFB-024 in Healthy Overweight and Obese Participants, and Participants With Type 2 Diabetes (NCT04880291) | Goldfinch Bio, Inc. | 2021-05-05 |
| Bioequivalence Study of Baricitinib From Barcimiant 4 mg Film Coated Tablets (Horus Pharma, Egypt) and Olumiant 4 mg Film Coated Tablets (Eli Lilly Nederland B.V., The Netherlands) (NCT05006768) | Genuine Research Center, Egypt | 2021-05-05 |
| Food Effect on Pharmacokinetics and Safety of DHP107 (Liporaxel®) FEEL Study (NCT04675528) | Daehwa Pharmaceutical Co., Ltd. | 2021-05-04 |
| To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Renal Function and Renal Impairment. (NCT04831996) | Incyte Corporation | 2021-05-04 |
| BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT) (NCT04296942) | National Cancer Institute (NCI) | 2021-05-04 |
| Food Effect and Bioequivalence Study of Simufilam Tablets in Healthy Volunteers (NCT04932655) | Cassava Sciences, Inc. | 2021-05-04 |
| A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY) (NCT04853576) | Editas Medicine, Inc. | 2021-05-04 |
| Study for the Treatment for CLN7 Disease (NCT04737460) | Benjamin Greenberg | 2021-05-04 |
| Evaluate Safety of Adipose Derived Mesenchymal Stem Cell Transplantation for Type 1 Diabetes Treatment (NCT05308836) | Vinmec Research Institute of Stem Cell and Gene Technology | 2021-05-04 |
| A Trial to Evaluate the Safety and PK Profile of HRS4800 in Healthy Subjects (NCT04862884) | Jiangsu HengRui Medicine Co., Ltd. | 2021-05-03 |
| ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer (NCT04662580) | Janssen Research & Development, LLC | 2021-05-03 |
| Drug-drug Interaction Study of Lemborexant as an Adjunctive Treatment for Buprenorphine/Naloxone for Opioid Use Disorder (NCT04818086) | Virginia Commonwealth University | 2021-05-03 |
| Drug-Drug Interaction (DDI) Study in Healthy Volunteers (NCT04814498) | Blade Therapeutics | 2021-05-03 |
| Substudy 02D: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Melanoma Brain Metastasis (MK-3475-02D/KEYMAKER-U02) (NCT04700072) | Merck Sharp & Dohme LLC | 2021-05-03 |
| A Study of LY3493269 in Healthy Participants (NCT04682106) | Eli Lilly and Company | 2021-05-03 |
| Mirtazapine and Methamphetamine Drug-drug Interaction Study (NCT04614584) | San Francisco Department of Public Health | 2021-05-03 |
| First-in-Human Study of SRT-015 in Healthy Subjects. (NCT04887038) | Syneos Health | 2021-05-03 |
| Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors (NCT04902872) | Cybrexa Therapeutics | 2021-05-03 |
| ChulaCov19 Vaccine in Healthy Adults (NCT04566276) | Chulalongkorn University | 2021-05-03 |
| Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics (NCT04315233) | University of Utah | 2021-05-03 |
| Multi Peptide Vaccination with XS15 in Addition to Standard Postoperative Radiation Therapy and Temozolomide Chemotherapy in Newly Diagnosed Glioblastoma (NCT04842513) | University Hospital Tuebingen | 2021-05-03 |
| Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease (NCT04802733) | BlueRock Therapeutics | 2021-05-03 |
| To Assess the Pharmacokinetics and Safety and Tolerability of Efanesoctocog Alfa (BIVV001)in Adults With Type 2N and 3 Von Willebrand Disease (VWD) (NCT04770935) | Bioverativ, a Sanofi company | 2021-05-03 |
| Phase 1 Study Using TRIMELVax for Stage IIIC / IV Melanoma Patients (NCT06556004) | University of Chile | 2021-05-02 |
| Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for the Treatment of Vitiligo (NCT05577637) | Combined Military Hospital Abbottabad | 2021-05-01 |
| Pharmacokinetics and Safety Following Administration of DWP16001 (NCT05414591) | Daewoong Pharmaceutical Co. LTD. | 2021-05-01 |
| Opioid Modulation and Neural Reward Activation in Healthy Adults (NCT04854551) | University of Colorado, Denver | 2021-05-01 |
| Sintilimab Combined With Bevacizumab Biosimilar for Potentially Resectable Intermediate HCC (NCT04843943) | Fudan University | 2021-05-01 |
| Effects of Intensive Training on Reocvery of Fingers Dexterity Following Stroke (NCT04229329) | Loewenstein Hospital | 2021-05-01 |
| Arista Hemostatic Powder for Total Knee Post Operative Outcomes Study (NCT05522153) | Virtua Health, Inc. | 2021-05-01 |
| Phase I Study of SC-43 Oral Solution in Subjects With Refractory Solid Tumors (NCT03443622) | SupremeCure Pharma Inc. | 2021-05-01 |
| Comparative Study Between Pulsed and Continuous Itraconazole for the Treatment of Onychomycosis (NCT05567484) | Combined Military Hospital Abbottabad | 2021-05-01 |
| A Phase I/II Study of Diffuse Large B-cell Lymphoma (NCT04856137) | National Health Research Institutes, Taiwan | 2021-05-01 |
| Clinical Study of HLA Haploidentical CAR-NK Cells Targeting CD19 in the Treatment of Refractory/Relapsed B-cell NHL (NCT04887012) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-05-01 |
| Clinical Trial to Assess Safety and Immunogenicity of a Synthetic Vaccine Against Streptococcus Pyogenes (NCT03998592) | Butantan Institute | 2021-05-01 |
| CPI-613 and Hydroxychloroquine for Patients With High Risk Myelodysplastic Syndrome (NCT03929211) | Wake Forest University Health Sciences | 2021-05-01 |
| A Phase 1/2 Study of SC-43 in Combination With Cisplatin (NCT04733521) | RaND Biosciences | 2021-05-01 |
| Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19_#2 (NCT04356677) | Bausch Health Americas, Inc. | 2021-05-01 |
| Effect of N-Acetylcysteine on Neutrophil Lymphocyte Ratio And Length of Stay In COVID-19 Patients (NCT05658549) | Universitas Sebelas Maret | 2021-05-01 |
| Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases (NCT04834089) | Butantan Institute | 2021-05-01 |
| Cough Desensitization Therapy: Pilot 2 (NCT05226299) | University of Montana | 2021-05-01 |
| A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With Osteosarcoma (NCT04886765) | AlaMab Therapeutics (Shanghai) Inc. | 2021-05-01 |
| Mechanism of Response to IMFINZI Neoadjuvant Therapy in Non-small Cell Lung Cancer Patients Based on Multiple-omics Models (NCT04646837) | Peking Union Medical College Hospital | 2021-05-01 |
| Anakinra in Previously Untreated Chronic Lymphocytic Leukemia Patients (NCT04691765) | Dr. David Spaner | 2021-05-01 |
| Neoadjuvant Electrochemotherapy for Colorectal Cancer - a Randomized Controlled Trial (NCT04816045) | Zealand University Hospital | 2021-05-01 |
| Melphalan Chemoreduction for Ocular Melanoma (NCT05893654) | Hospital das Clínicas de Ribeirão Preto | 2021-05-01 |
| Third-Generation CAR-T-cell Therapy in Individuals With HIV-1 Infection (NCT04863066) | Beijing 302 Hospital | 2021-05-01 |
| ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma (NCT04854044) | Jonsson Comprehensive Cancer Center | 2021-05-01 |
| Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant (NCT04177004) | City of Hope Medical Center | 2021-04-30 |
| A Study to Assess the Effect of Food on the Pharmacokinetics of TY-9591 in Healthy Volunteers (NCT04798638) | TYK Medicines, Inc | 2021-04-30 |
| Immunogenicity & Safety Study of Adenovirus Type 5 (AD5) Based Oral Norovirus Vaccines (NCT04875676) | Vaxart | 2021-04-30 |
| Combination of Ipi/Nivo Plus Sacituzumab Govitecan in Metastatic Cisplatin Ineligible Urothelial Carcinoma Patients (NCT04863885) | H. Lee Moffitt Cancer Center and Research Institute | 2021-04-30 |
| Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors (NCT04855656) | Debiopharm International SA | 2021-04-30 |
| A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843 (NCT04805606) | Chong Kun Dang Pharmaceutical | 2021-04-30 |
| Safety, Tolerability, and Pharmacokinetics of Sulopenem in Adolescents (NCT04700787) | Iterum Therapeutics, International Limited | 2021-04-30 |
| A Study of JNJ-67953964 in Healthy Japanese Adult Male Participants (NCT04791332) | Janssen Pharmaceutical K.K. | 2021-04-30 |
| A Study of Macitentan/Tadalafil Combination Administered a Fixed-dose Combination Formulation Compared to the Reference Free Combination of Macitentan and Tadalafil (NCT04540744) | Janssen Research & Development, LLC | 2021-04-30 |
| TQB2450 Combined With Anlotinib Hydrochloride in the Perioperative Treatment of Hepatocellular Carcinoma Hydrochloride Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With a High Risk of Recurrence or Metastasis (NCT04888546) | Chinese Academy of Medical Sciences | 2021-04-30 |
| Safety, Tolerability, Pharmacokinetics and Food Effects of Oral EC5026 in Healthy Subjects (NCT04908995) | EicOsis Human Health Inc. | 2021-04-30 |
| Changing Susceptible Body Constitution for COVID-19 Prevention by Chinese Medicine in Hong Kong Residents (NCT04668222) | The University of Hong Kong | 2021-04-30 |
| A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity. (NCT04752774) | Ipsen | 2021-04-29 |
| Investigating Effects of BOTOX on Weight Loss and Glucose Tolerance in Obese, Type 2 Diabetic Subjects (NCT03991299) | Vanderbilt University Medical Center | 2021-04-29 |
| A Study of AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma (NCT04740034) | Amgen | 2021-04-29 |
| Sequential Infusion of CD19 and BCMA CAR-T Cells to Improve PTR in Patients With AL (NCT04846439) | The First Affiliated Hospital of Soochow University | 2021-04-29 |
| A Study of CT-388 in Otherwise Healthy Overweight and Obese Adults and Patients With Type 2 Diabetes Mellitus (NCT04838405) | Carmot Therapeutics, Inc. | 2021-04-29 |
| Acalabrutinib and Durvalumab in Primary and Secondary Central Nervous System Lymphoma (NCT04462328) | Washington University School of Medicine | 2021-04-29 |
| L-citrulline Injection in Patients Aged 6-21 Years Old with Sickle Cell Disease Presenting with Vaso-Occlusive Crisis (VOC) (NCT04852172) | Asklepion Pharmaceuticals, LLC | 2021-04-29 |
| An Open-label Study to Define the Safety, Tolerability and Clinical Activity of Deutetrabenazine (AUstedo) in Adult Study Subjects With DYsTonia (NCT04173260) | University of Pennsylvania | 2021-04-29 |
| CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma (NCT04387071) | University of Southern California | 2021-04-29 |
| Study of AMG 994 Monotherapy and AMG 994 and AMG 404 Combination Therapy in Participants With Advanced Solid Tumors (NCT04727554) | Amgen | 2021-04-29 |
| A Single and Multiple Ascending Dose Study of Subcutaneously Administered JNJ-75220795 (NCT04844450) | Janssen Research & Development, LLC | 2021-04-29 |
| A Study of BBP-711 (ORF-229) in Healthy Adult Volunteers (NCT04876924) | Cantero Therapeutics, a BridgeBio company | 2021-04-29 |
| Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects (NCT04837235) | Tianjin Hemay Pharmaceutical Co., Ltd | 2021-04-29 |
| Aerobic Exercise for Remyelination in Multiple Sclerosis (NCT04539002) | Oregon Health and Science University | 2021-04-29 |
| A Study to Test the Safety, Tolerability, and Blood Levels of UCB0022 in Healthy Participants and Participants With Parkinson's Disease (NCT04867642) | UCB Biopharma SRL | 2021-04-29 |
| A Study To Assess Distribution Of RO7248824 In The Central Nervous System Following Single Intrathecal Doses Of [89zr] Labeled RO7248824 In Healthy Male Participants (NCT04863794) | Hoffmann-La Roche | 2021-04-29 |
| ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia. (NCT05038696) | National University Hospital, Singapore | 2021-04-28 |
| Safety and Immunogenicity of EXG-5003 (NCT04863131) | Fujita Health University | 2021-04-28 |
| A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Body of People From China With Type 2 Diabetes (NCT04857398) | Novo Nordisk A/S | 2021-04-28 |
| Study to Assess Safety and PET Imaging Characteristics of a Novel Senescence-specific Radiotracer [18F]FPyGal (2-[Fluorine-18]Fluoro-3-pyridinyl-β-D-galactopyranoside) (NCT04536454) | University Hospital Tuebingen | 2021-04-28 |
| Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia (NCT04806035) | TG Therapeutics, Inc. | 2021-04-28 |
| Study of the Efficacy and Safety of IBI319 in Patients With Advanced Malignant Tumors (NCT04708210) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-04-28 |
| The CAPER Trial: A Phase Ib Clinical Trial of Cyclophosphamide And PEmbrolizumab in Metastatic Renal Cell Carcinoma (NCT04262427) | The Christie NHS Foundation Trust | 2021-04-28 |
| Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination (NCT04868877) | Merus B.V. | 2021-04-28 |
| A Trial to Learn What Happens to Different Medicinal Forms of BAY2328065 When They Enter the Body and How Safe They Are in Healthy Male and Female Participants (NCT04851483) | Bayer | 2021-04-28 |
| Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours (NCT04808362) | Peptomyc S.L. | 2021-04-28 |
| Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis (NCT04754945) | Emory University | 2021-04-28 |
| ME-401 and R-CHOP in Newly Diagnosed Diffuse Large B-Cell Lymphoma (NCT04517435) | Deepa Jagadeesh | 2021-04-28 |
| A Study to Assess the Pharmacokinetics (PK) and Safety of Staccato Alprazolam in Adolescent Study Participants With Epilepsy (NCT04857307) | UCB Biopharma SRL | 2021-04-28 |
| A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Volunteers (NCT04867200) | Chong Kun Dang Pharmaceutical | 2021-04-27 |
| Testing the Addition of an Anti-cancer Drug, Entinostat, to the Usual Chemotherapy and Immunotherapy Treatment (Atezolizumab, Carboplatin and Etoposide) for Previously Untreated Aggressive Lung Cancer That Has Spread (NCT04631029) | National Cancer Institute (NCI) | 2021-04-27 |